In addition, a small pilot safety study published in Alternative Therapies in Health and Medicine showed that intravenous infusions of BPC-157 up to 20 milligrams were well-tolerated with no reported adverse effects in healthy adults, providing initial evidence that the peptide can be administered safely, a necessary step before larger efficacy trials on healing outcomes are conducted
Suda, S., Hiki, M., & Daida, H
For 99% of people seeking maximum medical weight loss, better options exist
BPC 157 should not be taken by anyone pregnant or nursing, has cancer, or has underlying vascular diseases unless under the close supervision of a physician
This information is for general educational purposes only and should not be used as a substitute for medical advice, diagnosis, or treatment